Immunoassay Market Size, Share & Trends Report

Immunoassay Market (2025 - 2030) Size, Share & Trends Analysis Report By Product, By Technology (Radioimmunoassay, Enzyme Immunoassays), By Application (Therapeutic Drug Monitoring, Oncology), By Specimen (Blood), By End-use, By Region, And Segment Forecasts

Market Segmentation

Immunoassay Product Outlook (Revenue, USD Million; 2018 - 2030)
- Reagents & Kits
  - ELISA Reagents & Kits
  - Rapid Tests Reagents & Kits
  - ELISPOT Reagents & Kits
  - Western Blot Reagents & Kits
  - Other Reagents & Kits
- Analyzers/Instruments
  - Open Ended Systems
  - Closed Ended Systems
- Software & Services
Immunoassay Application Outlook (Revenue, USD Million; 2018 - 2030)
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
Immunoassay Technology Outlook (Revenue, USD Million; 2018 - 2030)
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
  - Chemiluminescence Immunoassays (CLIA)
  - Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
Immunoassay Specimen Outlook (Revenue, USD Million; 2018 - 2030)
- Blood
- Saliva
- Urine
- Others
Immunoassay End Use Outlook (Revenue, USD Million; 2018 - 2030)
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
Immunoassay Regional Outlook (Revenue, USD Million; 2018 - 2030)
- North America
  - North America Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagents & Kits
      - ELISA Reagents & Kits
      - Rapid Tests Reagents & Kits
      - ELISPOT Reagents & Kits
      - Western Blot Reagents & Kits
      - Other Reagents & Kits
    - Analyzers/Instruments
      - Open Ended Systems
      - Closed Ended Systems
    - Software & Services
  - North America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Therapeutic Drug Monitoring
    - Oncology
    - Cardiology
    - Endocrinology
    - Infectious Disease Testing
    - Autoimmune Diseases
    - Others
  - North America Specimen Outlook (Revenue, USD Million, 2018 - 2030)
    - Blood
    - Saliva
    - Urine
    - Others
  - North America Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Radioimmunoassay (RIA)
    - Enzyme Immunoassays (EIA)
      - Chemiluminescence Immunoassays (CLIA)
      - Fluorescence Immunoassays (FIA)
    - Rapid Test
    - Others
  - North America End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals
    - Blood Banks
    - Clinical Laboratories
    - Pharmaceutical and Biotech Companies
    - Academic Research Centers
    - Others
  - U.S.
    - U.S. Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - U.S. Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - U.S. Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - U.S. Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - U.S. End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Canada
    - Canada Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Canada Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Canada Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Canada Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Canada End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Mexico
    - Mexico Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Mexico Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Mexico Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Mexico Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Mexico End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
- Europe
  - Europe Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagents & Kits
      - ELISA Reagents & Kits
      - Rapid Tests Reagents & Kits
      - ELISPOT Reagents & Kits
      - Western Blot Reagents & Kits
      - Other Reagents & Kits
    - Analyzers/Instruments
      - Open Ended Systems
      - Closed Ended Systems
    - Software & Services
  - Europe Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Therapeutic Drug Monitoring
    - Oncology
    - Cardiology
    - Endocrinology
    - Infectious Disease Testing
    - Autoimmune Diseases
    - Others
  - Europe Specimen Outlook (Revenue, USD Million, 2018 - 2030)
    - Blood
    - Saliva
    - Urine
    - Others
  - Europe Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Radioimmunoassay (RIA)
    - Enzyme Immunoassays (EIA)
      - Chemiluminescence Immunoassays (CLIA)
      - Fluorescence Immunoassays (FIA)
    - Rapid Test
    - Others
  - Europe End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals
    - Blood Banks
    - Clinical Laboratories
    - Pharmaceutical and Biotech Companies
    - Academic Research Centers
    - Others
  - UK
    - UK Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - UK Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - UK Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - UK Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - UK End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Germany
    - Germany Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Germany Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Germany Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Germany Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Germany End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - France
    - France Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - France Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - France Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - France Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - France End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Italy
    - Italy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Italy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Italy Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Italy Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Italy End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Spain
    - Spain Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Spain Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Spain Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Spain Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Spain End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Denmark
    - Denmark Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Denmark Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Denmark Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Denmark Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Denmark End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Sweden
    - Sweden Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Sweden Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Sweden Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Sweden Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Sweden End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Norway
    - Norway Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Norway Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Norway Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Norway Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Norway End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
- Asia Pacific
  - Asia Pacific Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagents & Kits
      - ELISA Reagents & Kits
      - Rapid Tests Reagents & Kits
      - ELISPOT Reagents & Kits
      - Western Blot Reagents & Kits
      - Other Reagents & Kits
    - Analyzers/Instruments
      - Open Ended Systems
      - Closed Ended Systems
    - Software & Services
  - Asia Pacific Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Therapeutic Drug Monitoring
    - Oncology
    - Cardiology
    - Endocrinology
    - Infectious Disease Testing
    - Autoimmune Diseases
    - Others
  - Asia Pacific Specimen Outlook (Revenue, USD Million, 2018 - 2030)
    - Blood
    - Saliva
    - Urine
    - Others
  - Asia Pacific Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Radioimmunoassay (RIA)
    - Enzyme Immunoassays (EIA)
      - Chemiluminescence Immunoassays (CLIA)
      - Fluorescence Immunoassays (FIA)
    - Rapid Test
    - Others
  - Asia Pacific End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals
    - Blood Banks
    - Clinical Laboratories
    - Pharmaceutical and Biotech Companies
    - Academic Research Centers
    - Others
  - China
    - China Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - China Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - China Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - China Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - China End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Japan
    - Japan Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Japan Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Japan Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Japan Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Japan End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - India
    - India Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - India Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - India Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - India Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - India End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Australia
    - Australia Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Australia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Australia Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Australia Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Australia End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - South Korea
    - South Korea Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - South Korea Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - South Korea Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - South Korea Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - South Korea End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Thailand
    - Thailand Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Thailand Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Thailand Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Thailand Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Thailand End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
- Latin America
  - Latin America Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagents & Kits
      - ELISA Reagents & Kits
      - Rapid Tests Reagents & Kits
      - ELISPOT Reagents & Kits
      - Western Blot Reagents & Kits
      - Other Reagents & Kits
    - Analyzers/Instruments
      - Open Ended Systems
      - Closed Ended Systems
    - Software & Services
  - Latin America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Therapeutic Drug Monitoring
    - Oncology
    - Cardiology
    - Endocrinology
    - Infectious Disease Testing
    - Autoimmune Diseases
    - Others
  - Latin America Specimen Outlook (Revenue, USD Million, 2018 - 2030)
    - Blood
    - Saliva
    - Urine
    - Others
  - Latin America Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Radioimmunoassay (RIA)
    - Enzyme Immunoassays (EIA)
      - Chemiluminescence Immunoassays (CLIA)
      - Fluorescence Immunoassays (FIA)
    - Rapid Test
    - Others
  - Latin America End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals
    - Blood Banks
    - Clinical Laboratories
    - Pharmaceutical and Biotech Companies
    - Academic Research Centers
    - Others
  - Brazil
    - Brazil Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Brazil Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Brazil Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Brazil Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Brazil End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Argentina
    - Argentina Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Argentina Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Argentina Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Argentina Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Argentina End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
- Middle East and Africa (MEA)
  - MEA Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagents & Kits
      - ELISA Reagents & Kits
      - Rapid Tests Reagents & Kits
      - ELISPOT Reagents & Kits
      - Western Blot Reagents & Kits
      - Other Reagents & Kits
    - Analyzers/Instruments
      - Open Ended Systems
      - Closed Ended Systems
    - Software & Services
  - MEA Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Therapeutic Drug Monitoring
    - Oncology
    - Cardiology
    - Endocrinology
    - Infectious Disease Testing
    - Autoimmune Diseases
    - Others
  - MEA Specimen Outlook (Revenue, USD Million, 2018 - 2030)
    - Blood
    - Saliva
    - Urine
    - Others
  - MEA Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Radioimmunoassay (RIA)
    - Enzyme Immunoassays (EIA)
      - Chemiluminescence Immunoassays (CLIA)
      - Fluorescence Immunoassays (FIA)
    - Rapid Test
    - Others
  - MEA End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals
    - Blood Banks
    - Clinical Laboratories
    - Pharmaceutical and Biotech Companies
    - Academic Research Centers
    - Others
  - South Africa
    - South Africa Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - South Africa Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - South Africa Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - South Africa Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - South Africa End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Saudi Arabia
    - Saudi Arabia Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Saudi Arabia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Saudi Arabia Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Saudi Arabia Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Saudi Arabia End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - UAE
    - UAE Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - UAE Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - UAE Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - UAE Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - UAE End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others
  - Kuwait
    - Kuwait Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents & Kits
        
        ELISA Reagents & Kits
        
        Rapid Tests Reagents & Kits
        
        ELISPOT Reagents & Kits
        
        Western Blot Reagents & Kits
        
        Other Reagents & Kits
      - Analyzers/Instruments
        
        Open Ended Systems
        
        Closed Ended Systems
      - Software & Services
    - Kuwait Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic Drug Monitoring
      - Oncology
      - Cardiology
      - Endocrinology
      - Infectious Disease Testing
      - Autoimmune Diseases
      - Others
    - Kuwait Specimen Outlook (Revenue, USD Million, 2018 - 2030)
      - Blood
      - Saliva
      - Urine
      - Others
    - Kuwait Sample Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Radioimmunoassay (RIA)
      - Enzyme Immunoassays (EIA)
        
        Chemiluminescence Immunoassays (CLIA)
        
        Fluorescence Immunoassays (FIA)
      - Rapid Test
      - Others
    - Kuwait End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Blood Banks
      - Clinical Laboratories
      - Pharmaceutical and Biotech Companies
      - Academic Research Centers
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments